Santen Pharmaceutical
4536.T
$9.39
Share price
0.66%
Change (1 day)
16.50%
Change (1 year)
Categories
P/S ratio for Santen Pharmaceutical (4536.T)
P/S ratio as of April 2024 (TTM): 1.59
According to Santen Pharmaceutical 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.58983. At the end of 2023 the company had a P/S ratio of 1.70.
P/S ratio history for Santen Pharmaceutical from 2009 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 1.70 | 11.23% |
| 2022 | 1.53 | -26.3% |
| 2021 | 2.08 | -27.28% |
| 2020 | 2.85 | -16.78% |
| 2019 | 3.43 | 22.05% |
| 2018 | 2.81 | -14.8% |
| 2017 | 3.30 | 17.94% |
| 2016 | 2.80 | -34.73% |
| 2015 | 4.29 | 38.23% |
| 2014 | 3.10 | 12.95% |
| 2013 | 2.74 | 24.01% |
| 2012 | 2.21 | -9.33% |
| 2011 | 2.44 | 2.04% |
| 2010 | 2.39 | 3.76% |
| 2009 | 2.31 |